Literature DB >> 16265904

Experimental models of cerebral malaria.

C Engwerda1, E Belnoue, A C Grüner, L Rénia.   

Abstract

Malaria remains a major global health problem and cerebral malaria is one of the most serious complications of this disease. Recent years have seen important advances in our understanding of the pathogenesis of cerebral malaria. Extensive analysis of tissues and blood taken from patients with cerebral malaria has been complimented by the use of animal models to identify specific components of pathogenic pathways. In particular, an important role for CD8+ T cells has been uncovered, as well divergent roles for members of the tumor necrosis factor (TNF) family of molecules, including TNF and lymphotoxin alpha. It has become apparent that there maybe more than one pathogenic pathway leading to cerebral malaria. The last few years have also seen the testing of vaccines designed to target malaria molecules that stimulate inflammatory responses and thereby prevent the development of cerebral malaria. In this review, we will discuss the above advancements, as well as other important findings in research into the pathogenesis of cerebral malaria. As our understanding of pathogenic responses to Plasmodium parasites gathers momentum, the chance of a breakthrough in the development of treatments and vaccines to prevent death from cerebral malaria have become more realistic.

Entities:  

Mesh:

Year:  2005        PMID: 16265904

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN: 0070-217X            Impact factor:   4.291


  74 in total

1.  Damage to the blood-brain barrier during experimental cerebral malaria results from synergistic effects of CD8+ T cells with different specificities.

Authors:  Chek Meng Poh; Shanshan W Howland; Gijsbert M Grotenbreg; Laurent Rénia
Journal:  Infect Immun       Date:  2014-08-25       Impact factor: 3.441

2.  Synthesis of artemiside and its effects in combination with conventional drugs against severe murine malaria.

Authors:  Jin Guo; Armand W Guiguemde; Annael Bentura-Marciano; Julie Clark; Richard K Haynes; Wing-Chi Chan; Ho-Ning Wong; Nicholas H Hunt; R Kiplin Guy; Jacob Golenser
Journal:  Antimicrob Agents Chemother       Date:  2011-10-17       Impact factor: 5.191

3.  Expression of Tim-1 and Tim-3 in Plasmodium berghei ANKA infection.

Authors:  Bo Huang; Man Liu; Shiguang Huang; Bin Wu; Hong Guo; Xin-Zhuan Su; Fangli Lu
Journal:  Parasitol Res       Date:  2013-05-08       Impact factor: 2.289

4.  Association of a functional TNF variant with Plasmodium falciparum parasitaemia in a congolese population.

Authors:  T N Nguyen; S Baaklini; F Koukouikila-Koussounda; M Ndounga; M Torres; L Pradel; F Ntoumi; P Rihet
Journal:  Genes Immun       Date:  2017-07-13       Impact factor: 2.676

5.  Inhibition of hypoxia-associated response and kynurenine production in response to hyperbaric oxygen as mechanisms involved in protection against experimental cerebral malaria.

Authors:  Marcele F Bastos; Ana Carolina A V Kayano; João Luiz Silva-Filho; João Conrado K Dos-Santos; Carla Judice; Yara C Blanco; Nathaniel Shryock; Michelle K Sercundes; Luana S Ortolan; Carolina Francelin; Juliana A Leite; Rafaella Oliveira; Rosa M Elias; Niels O S Câmara; Stefanie C P Lopes; Letusa Albrecht; Alessandro S Farias; Cristina P Vicente; Claudio C Werneck; Selma Giorgio; Liana Verinaud; Sabrina Epiphanio; Claudio R F Marinho; Pritesh Lalwani; Rogerio Amino; Julio Aliberti; Fabio T M Costa
Journal:  FASEB J       Date:  2018-03-20       Impact factor: 5.191

6.  CD8+ T cells and human cerebral malaria: a shifting episteme.

Authors:  Laurent Rénia; Georges Er Grau; Samuel C Wassmer
Journal:  J Clin Invest       Date:  2020-03-02       Impact factor: 14.808

7.  Plasmepsin 4-deficient Plasmodium berghei are virulence attenuated and induce protective immunity against experimental malaria.

Authors:  Roberta Spaccapelo; Chris J Janse; Sara Caterbi; Blandine Franke-Fayard; J Alfredo Bonilla; Luke M Syphard; Manlio Di Cristina; Tania Dottorini; Andrea Savarino; Antonio Cassone; Francesco Bistoni; Andrew P Waters; John B Dame; Andrea Crisanti
Journal:  Am J Pathol       Date:  2009-12-17       Impact factor: 4.307

8.  The NK cell granule protein NKG7 regulates cytotoxic granule exocytosis and inflammation.

Authors:  Susanna S Ng; Fabian De Labastida Rivera; Juming Yan; Dillon Corvino; Indrajit Das; Ping Zhang; Rachel Kuns; Shashi Bhushan Chauhan; Jiajie Hou; Xian-Yang Li; Teija C M Frame; Benjamin A McEnroe; Eilish Moore; Jinrui Na; Jessica A Engel; Megan S F Soon; Bhawana Singh; Andrew J Kueh; Marco J Herold; Marcela Montes de Oca; Siddharth Sankar Singh; Patrick T Bunn; Amy Roman Aguilera; Mika Casey; Matthias Braun; Nazanin Ghazanfari; Shivangi Wani; Yulin Wang; Fiona H Amante; Chelsea L Edwards; Ashraful Haque; William C Dougall; Om Prakash Singh; Alan G Baxter; Michele W L Teng; Alex Loukas; Norelle L Daly; Nicole Cloonan; Mariapia A Degli-Esposti; Jude Uzonna; William R Heath; Tobias Bald; Siok-Keen Tey; Kyohei Nakamura; Geoffrey R Hill; Rajiv Kumar; Shyam Sundar; Mark J Smyth; Christian R Engwerda
Journal:  Nat Immunol       Date:  2020-08-24       Impact factor: 25.606

9.  Transforming growth factor beta 2 and heme oxygenase 1 genes are risk factors for the cerebral malaria syndrome in Angolan children.

Authors:  Maria Rosário Sambo; Maria Jesus Trovoada; Carla Benchimol; Vatúsia Quinhentos; Lígia Gonçalves; Rute Velosa; Maria Isabel Marques; Nuno Sepúlveda; Taane G Clark; Stefan Mustafa; Oswald Wagner; António Coutinho; Carlos Penha-Gonçalves
Journal:  PLoS One       Date:  2010-06-16       Impact factor: 3.240

10.  Schistosoma mansoni infection reduces the incidence of murine cerebral malaria.

Authors:  Judith H Waknine-Grinberg; Daniel Gold; Ariel Ohayon; Eliezer Flescher; Alina Heyfets; Michael J Doenhoff; Gabriele Schramm; Helmut Haas; Jacob Golenser
Journal:  Malar J       Date:  2010-01-05       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.